Portfolio concentration
As of January 30, 2026 · N-PORT
Holdings
53
Top-10 weight
42.09%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
35
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
668.2
Holdings
As of January 30, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | FORTE BIOSCIENCES INC | — | 120,918 | $3.54M | 5.49% |
| 2 | TEVA PHARMACEUTICAL IND ADR | — | 89,555 | $3.05M | 4.74% |
| 3 | LILLY ELI and CO | — | 2,853 | $2.96M | 4.59% |
| 4 | CARDINAL HEALTH INC | — | 13,616 | $2.93M | 4.54% |
| 5 | IMPULSE DYNAMICS IRELAND | — | 48,744,272 | $2.78M | 4.31% |
| 6 | BIOGEN INC | — | 13,918 | $2.50M | 3.89% |
| 7 | ASTRAZENECA PLC SPONS ADR | — | 26,360 | $2.45M | 3.80% |
| 8 | CENTENE CORP | — | 53,722 | $2.33M | 3.61% |
| 9 | ARROWHEAD PHARMACEUTICALS INC | — | 32,938 | $2.28M | 3.55% |
| 10 | JOHNSON&JOHNSON | — | 9,368 | $2.13M | 3.31% |
| 11 | MODERNA INC | — | 45,883 | $2.02M | 3.14% |
| 12 | GUARDANT HEALTH INC | — | 17,220 | $1.96M | 3.05% |
| 13 | SANDOZ GROUP AG | — | 24,548 | $1.94M | 3.02% |
| 14 | ABBVIE INC | — | 8,548 | $1.91M | 2.96% |
| 15 | REPLIGEN CORP | — | 10,358 | $1.55M | 2.40% |
| 16 | CVS HEALTH CORP | — | 20,356 | $1.52M | 2.36% |
| 17 | NATERA INC | — | 6,456 | $1.49M | 2.32% |
| 18 | WUXI APPTEC CO LTD H | — | 99,511 | $1.42M | 2.20% |
| 19 | ICU MEDICAL INC | — | 9,157 | $1.37M | 2.13% |
| 20 | REVOLUTION MEDICINES INC | — | 14,146 | $1.37M | 2.13% |
| 21 | ROIVANT SCIENCES LTD | — | 57,237 | $1.24M | 1.92% |
| 22 | BROOKDALE SR | — | 79,264 | $1.19M | 1.85% |
| 23 | INTEGER HOLDINGS CORP | — | 12,551 | $1.09M | 1.69% |
| 24 | Abivax SA SPONSORED ADS | ABVX US | 9,738 | $1.08M | 1.68% |
| 25 | GILEAD SCIENCES INC | — | 7,221 | $1.03M | 1.59% |
| 26 | ADAPTIVE BIOTECHNOLOGIES CORP | — | 55,203 | $1.02M | 1.59% |
| 27 | CORVUS PHARMACEUTICALS INC | — | 48,609 | $1.01M | 1.56% |
| 28 | UNITED THERAPEUTICS CORP DEL | — | 2,091 | $981.70K | 1.52% |
| 29 | COGENT BIOSCIENCES INC | — | 25,200 | $904.93K | 1.40% |
| 30 | BELITE BIO INC ADR | BLTE | 4,535 | $766.42K | 1.19% |
| 31 | VIRIDIAN THERAPEUTICS INC | — | 21,297 | $702.80K | 1.09% |
| 32 | MCKESSON CORP | — | 832 | $691.57K | 1.07% |
| 33 | NEKTAR THERAPEUTICS | — | 18,409 | $687.21K | 1.07% |
| 34 | LIGAND PHARMACEUTICALS | — | 3,345 | $642.57K | 1.00% |
| 35 | NUVALENT INC-A | — | 6,208 | $638.74K | 0.99% |
| 36 | HEARTFLOW INC | — | 21,370 | $638.32K | 0.99% |
| 37 | THERMO FISHER SCIENTIFIC INC | — | 1,102 | $637.63K | 0.99% |
| 38 | TWIST BIOSCIENCE CORP | — | 14,910 | $612.35K | 0.95% |
| 39 | TRAVERE THERAPEUTICS INC | — | 19,597 | $609.27K | 0.95% |
| 40 | 10X GENOMICS INC | — | 29,825 | $602.46K | 0.94% |
| 41 | BRUKER CORP | — | 13,581 | $601.50K | 0.93% |
| 42 | TERNS PHARMACEUTICALS INC | — | 16,610 | $574.71K | 0.89% |
| 43 | CYTOKINETICS INC | — | 8,249 | $521.25K | 0.81% |
| 44 | INTUITIVE SURGICAL INC | — | 917 | $462.37K | 0.72% |
| 45 | UNIQURE N.V. | — | 19,194 | $436.09K | 0.68% |
| 46 | OSCAR HEALTH INC - CLASS A | — | 29,652 | $425.51K | 0.66% |
| 47 | Short-Term Investment | DTRXX | 350,612 | $350.61K | 0.54% |
| 48 | TENET HEALTHCARE CORP | — | 1,066 | $201.77K | 0.31% |
| 49 | IMPULSE DYNAMICS IRELAND | — | 5,000,001 | $185.00K | 0.29% |
| 50 | BOSTON SCIENTIFIC CORP | — | 1,780 | $166.48K | 0.26% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.